131 related articles for article (PubMed ID: 10875318)
1. Weak androgen levels, glucocorticoid therapy, and bone mineral density in postmenopausal women with rheumatoid arthritis.
Fiter J; Nolla JM; Navarro MA; Gómez-Vaquero C; Rosel P; Mateo L; Roig-Escofet D
Joint Bone Spine; 2000; 67(3):199-203. PubMed ID: 10875318
[TBL] [Abstract][Full Text] [Related]
2. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
3. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
[TBL] [Abstract][Full Text] [Related]
4. Soft tissue composition, axial bone mineral density, and grip strength in postmenopausal Turkish women with early rheumatoid arthritis: Is lean body mass a predictor of bone mineral density in rheumatoid arthritis?
Sahin G; Guler H; Incel N; Sezgin M; As I
Int J Fertil Womens Med; 2006; 51(2):70-4. PubMed ID: 16881382
[TBL] [Abstract][Full Text] [Related]
5. The effect of circulating androgens on bone mineral density in postmenopausal women.
Tok EC; Ertunc D; Oz U; Camdeviren H; Ozdemir G; Dilek S
Maturitas; 2004 Jul; 48(3):235-42. PubMed ID: 15207889
[TBL] [Abstract][Full Text] [Related]
6. Depressed levels of dehydroepiandrosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density.
Hall GM; Perry LA; Spector TD
Ann Rheum Dis; 1993 Mar; 52(3):211-4. PubMed ID: 8484674
[TBL] [Abstract][Full Text] [Related]
7. The effect of circulating nitric oxide level on axial bone mineral density in postmenopausal Turkish women with rheumatoid arthritis: A preliminary report.
Sahin G; Guler H; Sezgin M; Incel NA; Polat G
Rheumatol Int; 2006 Jul; 26(9):805-9. PubMed ID: 16362366
[TBL] [Abstract][Full Text] [Related]
8. Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women.
Papierska L; Rabijewski M; Kasperlik-Załuska A; Zgliczyński W
Adv Med Sci; 2012 Jun; 57(1):51-7. PubMed ID: 22430044
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of body composition and bone mineral density in women with rheumatoid arthritis].
Silva RG; Pippa MG; Zerbin CA
Rev Assoc Med Bras (1992); 2007; 53(2):135-41. PubMed ID: 17568917
[TBL] [Abstract][Full Text] [Related]
10. Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up.
Hämäläinen H; Kaarela K; Kröger H; Kauppi M; Järvenpää S; Hakala M; Kotaniemi A
Joint Bone Spine; 2007 Oct; 74(5):482-7. PubMed ID: 17905634
[TBL] [Abstract][Full Text] [Related]
11. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
Book C; Karlsson M; Akesson K; Jacobsson L
Scand J Rheumatol; 2008; 37(4):248-54. PubMed ID: 18612924
[TBL] [Abstract][Full Text] [Related]
12. Sex hormone status and bone mineral density in men with rheumatoid arthritis.
Mateo L; Nolla JM; Bonnin MR; Navarro MA; Roig-Escofet D
J Rheumatol; 1995 Aug; 22(8):1455-60. PubMed ID: 7473465
[TBL] [Abstract][Full Text] [Related]
13. Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis.
Sambrook PN; Eisman JA; Champion GD; Pocock NA
Arthritis Rheum; 1988 Aug; 31(8):973-8. PubMed ID: 2970263
[TBL] [Abstract][Full Text] [Related]
14. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T
Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B
Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926
[TBL] [Abstract][Full Text] [Related]
16. The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis.
Fassio A; Idolazzi L; Jaber MA; Dartizio C; Viapiana O; Rossini M; Gatti D
Reumatismo; 2016 Sep; 68(2):65-71. PubMed ID: 27608794
[TBL] [Abstract][Full Text] [Related]
17. The association of dehydroepiandrosterone sulphate levels with bone mineral density in systemic lupus erythematosus.
Formiga F; Moga I; Nolla JM; Navarro MA; Bonnin R; Roig-Escofet D
Clin Exp Rheumatol; 1997; 15(4):387-92. PubMed ID: 9272299
[TBL] [Abstract][Full Text] [Related]
18. Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study.
Uchida K; Nakajima H; Miyazaki T; Yayama T; Kawahara H; Kobayashi S; Tsuchida T; Okazawa H; Fujibayashi Y; Baba H
J Nucl Med; 2009 Nov; 50(11):1808-14. PubMed ID: 19837766
[TBL] [Abstract][Full Text] [Related]
19. Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis.
Wang Y; Zhao R; Gu Z; Dong C; Guo G; Li L
Osteoporos Int; 2020 Aug; 31(8):1401-1409. PubMed ID: 32291467
[TBL] [Abstract][Full Text] [Related]
20. Influence of bisphosphonate therapy on bone geometry, volumetric bone density and bone strength of femoral shaft in postmenopausal women with rheumatoid arthritis.
Meinen R; Galli-Lysak I; Villiger PM; Aeberli D
BMC Musculoskelet Disord; 2016 Aug; 17():324. PubMed ID: 27491286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
